CN103819479A - Pyrimidine group contained rigid conjugated macrocyclic compound as well as preparation method and application thereof - Google Patents

Pyrimidine group contained rigid conjugated macrocyclic compound as well as preparation method and application thereof Download PDF

Info

Publication number
CN103819479A
CN103819479A CN201410086053.XA CN201410086053A CN103819479A CN 103819479 A CN103819479 A CN 103819479A CN 201410086053 A CN201410086053 A CN 201410086053A CN 103819479 A CN103819479 A CN 103819479A
Authority
CN
China
Prior art keywords
compound
pyrimidine group
conjugate macrocycle
macrocycle compound
containing pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410086053.XA
Other languages
Chinese (zh)
Other versions
CN103819479B (en
Inventor
金武松
张灯青
肖朵朵
李贤英
陈北华
宁如光
张振
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Donghua University
Original Assignee
Donghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donghua University filed Critical Donghua University
Priority to CN201410086053.XA priority Critical patent/CN103819479B/en
Publication of CN103819479A publication Critical patent/CN103819479A/en
Application granted granted Critical
Publication of CN103819479B publication Critical patent/CN103819479B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0013Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/04Esters of boric acids
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1074Heterocyclic compounds characterised by ligands containing more than three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1096Heterocyclic compounds characterised by ligands containing other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a pyrimidine group contained rigid conjugated macrocyclic compound as well as a preparation method and an application thereof. A structure formula of the compound is shown in the specification, wherein n is equal to 1, 2, 3, 4 and 5. The preparation method comprises the steps as follows: for a rigid part, 1, 3-dibromo-5-fluorobenzene is taken as a raw material to synthesize 1, 3-dibromo-5-methoxybenzene, and 3, 5-dibromophenol is synthesized through a boron tribromide demethylation reaction; for a linear part, 3-chloro-2-chloromethyl-1-propene is adopted as a starting material to obtain a linear part intermediate, and then under the alkaline condition, 3, 5-dibromophenol and the linear part intermediate synthesize 3, 5-dibromobenzene long-chain ether which has Miyaura reaction with bis(pinacolato) diboron to synthesize a monomer II; the monomer II and 5-bromo-2-iodopyrimidine have a Suzuki coupled reaction to synthesize a monomer III; and the monomer II and the monomer III are subjected to Suzuki coupling to obtain the compound. The obtained compound is taken as a functional material for application.

Description

A kind of containing pyrimidine group rigidity Conjugate macrocycle compound and its preparation method and application
Technical field
The invention belongs to Conjugate macrocycle compound and preparation thereof and Application Areas, particularly a kind of containing pyrimidine group rigidity Conjugate macrocycle compound and its preparation method and application.
Background technology
The eighties in last century supramolecular chemistry concept proposition till now, supramolecular chemistry has experienced rapidly development.Wherein, the supramolecular materials of stimuli responsive has become the study hotspot in supramolecular chemistry field to external world, especially utilizes the organic supramolecular of π-electron conjugated system, the material that polymer is essentially consist unit, and its design and development is more and more active.Related to this, the rigid macrocyclic compound and the derivative thereof that have ordered structure, Pi-conjugated systems are just being subject to huge attracting attention.The rich pi-conjugated compound of this class is according to the position of its polar functional group and orientation, the mutual accumulation of extremely strong π-π having by itself is easy to occur self-assembly, thereby make large ring form solid-state one dimension column non covalent bond macromolecule aggregation body structure, solid-state two-dimensional network structure and 3-D nano, structure.The one dimension of this high-sequential, two dimension, three-dimensional structure can be the carrier such as hole, electronics possible moving passage are provided.As the electronics of brand-new demonstration anisotropic properties and photoelectron material material and caused the great interest of scientists.
Containing the heteroatomic Conjugate macrocycle compound of N as the emerging Conjugate macrocycle compound of a class because its potential function and application is subject to extensive concern.Conjugate macrocycle compound containing pyrimidine group is one of representative of this compounds, they have very regular shape and structure, ring diameter is in Nano grade, according to the difference of its stiffening ring skeleton and the upper flexible chain of ring, this class Conjugate macrocycle compound can be piled up or one dimension, two and three dimensions supramolecular structure are constructed in concave-convex interaction self-assembly by self π-π, also can be used together the contained N heteroatoms of pyrimidine has in conjunction with proton, the abilities such as metal ion, study and can respond to the responsiveness functional materials of external stimulus for the preparation of matrix material.Therefore, during this class macrocylc compound is developed to new function material as good self-assembly unit molecular application.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of containing pyrimidine group rigidity Conjugate macrocycle compound and its preparation method and application, and gained compound of the present invention can be used as good self-assembly unit molecular application in new function material exploitation; The present invention can, by self contained N heteroatoms and metal-complexing, present special photoelectric properties, studies for matrix material; The present invention can be by preparing Modulatory character fluorescent material to sour induction.In addition, can there is by the size selectivity induction preparation to guest molecule the matrix material of different optical and electricity.
One of the present invention is containing pyrimidine group rigidity Conjugate macrocycle compound, and the general structure of described compound is:
Figure BDA0000475024820000021
wherein n=1,2,3,4,5; Wherein, R is independently selected from one or more in hydrophobicity long chain alkyl group, hydrophilic long-chain group, chirality long chain alkyl group, ester group, cyano group, amino, aryl, sulfydryl separately.
Described R is independently hydrophobicity long chain alkyl group or hydrophilic long-chain group separately, and compound is:
Figure BDA0000475024820000022
in one; Wherein n=1,2,3,4,5.
Described compound is expanded through side chain:
Figure BDA0000475024820000031
wherein n=1,2,3,4,5.
N atom on described compound pyrimidine group and Pt coordination, the structural formula after coordination is:
Figure BDA0000475024820000032
in one, wherein n=1,2,3,4,5.
N atom on described compound pyrimidine group and Pt, Pd or Ru coordination.
A kind of preparation method containing pyrimidine group rigidity Conjugate macrocycle compound of the present invention, comprising:
(1) rigid element is with 3, 5-bis-bromofluoro benzenes are raw material, synthesize 3 by substitution reaction, 5-dibromobenzene methyl ether, again through boron tribromide demethylation reaction synthetic 3, 5-dibromophenol, it is starting raw material that linear portion adopts the chloro-2-chloromethyl propylene of 3-, through three step (condensations, hydroboration oxidation, tosylation) obtain linear portion intermediate, afterwards 3, 5-dibromophenol synthesizes 3 with linear portion intermediate by nucleophilic substitution reaction again under alkaline condition, 5-dibromobenzene long chain ether, utilize 3, 5-dibromobenzene long chain ether and two tetramethyl ethylene ketones close two boron to carry out Miyaura and reacts synthon II,
(2) bromo-2 iodine pyrimidines of monomer II and 5-are by Suzuki linked reaction synthon III;
(3) utilize monomer II and monomer II I synthetic containing pyrimidine group rigidity Conjugate macrocycle compound by Suzuki coupling one step to form the loop method.
A kind of application containing pyrimidine group rigidity Conjugate macrocycle compound of the present invention, the described pyrimidine group rigidity Conjugate macrocycle compound that contains is developed in functional materials as self-assembly unit molecular application.
A kind of application containing pyrimidine group rigidity Conjugate macrocycle compound of the present invention, the described coordination containing pyrimidine group rigidity Conjugate macrocycle compound and metal is for the preparation of the matrix material with difference in functionality.
A kind of application containing pyrimidine group rigidity Conjugate macrocycle compound of the present invention, described have reversibility containing pyrimidine group rigidity Conjugate macrocycle compound to the responsiveness of PH, for regulating and controlling fluorescent material research.
A kind of application containing pyrimidine group rigidity Conjugate macrocycle compound of the present invention, prepares the matrix material with different optical and electricity by the size selectivity induction to guest molecule.
Secondly the present invention provides a kind of and has formed the research of supramolecular structure body for functional materials exploitation containing pyrimidine group rigidity Conjugate macrocycle compound through self-assembly.Compound of the present invention has regular molecular structure, pore size is in Nano grade, can pile up or one dimension, two and three dimensions supramolecular structure are constructed in concave-convex interaction self-assembly by self π-π, as good self-assembly unit molecular application in new function material exploitation; In addition, can also utilize the contained N heteroatoms of pyrimidine to have in conjunction with proton, the abilities such as metal ion, study and can respond to the responsiveness functional materials of external stimulus for the preparation of matrix material.
beneficial effect
(1) the invention provides series of new containing pyrimidine group rigidity Conjugate macrocycle compound one step to form the loop synthesis method, possess raw material synthetic method simple, mature preparation process, productive rate is compared with advantages of higher;
(2) the present invention can be used as good self-assembly unit molecular application in new function material exploitation;
(3) the present invention can, by self contained N heteroatoms and metal-complexing, present special photoelectric properties, studies for matrix material;
(4) the present invention can be by preparing Modulatory character fluorescent material and electronically active material (transfer transport or energy shift) to sour induction;
(5) the present invention can have by the size selectivity induction preparation to guest molecule the matrix material of different optical and electricity.
Accompanying drawing explanation
Fig. 1 is the GPC separation graph of embodiment 9 products;
Fig. 2 is target product I in embodiment 9 1, I 2, I 3mALDI-TOF Mass figure;
Fig. 3 is the middle I of embodiment 9 products 1to the fluorescence spectrum figure of sour responsiveness, the responsiveness fluorescence spectrum figure (b) to alkali to sour responsiveness fluorescence spectrum figure (a) and continuation.
Embodiment
Below in conjunction with specific embodiment, further set forth the present invention.Should be understood that these embodiment are only not used in and limit the scope of the invention for the present invention is described.In addition should be understood that those skilled in the art can make various changes or modifications the present invention after having read the content of the present invention's instruction, these equivalent form of values fall within the application's appended claims limited range equally.
Rigid element adopts 3, 5-bis-bromofluoro benzenes are starting raw material, synthesize 3 by substitution reaction, 5-dibromobenzene methyl ether, synthesize 3 by boron tribromide demethylation reaction, 5-dibromophenol (Davidson J P, Sarma K, Fishlock D, et al.Synthesis of 3, 5-Disubstituted Phenols[J] .Org Process Res Dev, 2010, 14 (2): 477-480.), in addition, it is starting raw material that linear portion adopts the chloro-2-chloromethyl propylene of 3-, through three step (condensations, hydroboration oxidation, tosylation) can obtain smoothly (Davies, P.J., Grove, D.M., van.Koten, G., Advances in the synthesis of multimetalllic systems:hydroxyl group protection in (aryldiamine) platinum species.Organometallics1997,16 (4), 800-802.).3,5-dibromophenol and linear portion intermediate 7 synthesize 11 by nucleophilic substitution reaction.Utilize 11 to close two boron with two tetramethyl ethylene ketones and carry out Miyaura and react synthetic boric acid ester centre monomer 2a, after by 2a and bromo-2 iodine pyrimidines of 5-by Suzuki linked reaction synthon 3a, finally utilize monomer 2a and 3a by the synthetic target macrocylc compound Ia of Suzuki coupling one step to form the loop method.
Figure BDA0000475024820000051
Embodiment 1
Synthesizing of compound 5
Add NaH (19.2g to being equipped with in two mouthfuls of flasks of 500mL of magnetic stir bar and reflux; 0.8mol, 7.4eq.), under the protection of Ar gas; substitute gas three times; add anhydrous THF (250mL), add 3-chloro-2-chloromethyl propylene (13.5g, 0.11mol; 1eq.); dropwise add 1-lauryl alcohol (42.3g, 0.227mol, 2.1eq.).At 65 ℃, back flow reaction is spent the night, and is cooled to room temperature, and the cancellation that adds water reaction is revolved to steam and revolved THF, uses CH 2cl 2extraction (50mL × 3), merging organic phase, distillation washing (50mL × 3), anhydrous magnesium sulfate drying organic phase, removes by filter magnesium sulfate, revolves to steam to desolventize silica gel column chromatography purification (eluent: PE/CH for residuum 2cl 2=5/1), obtain colourless liquid 32.4g, productive rate 75%. 1H?NMR(400MHz,CDCl 3):δ5.14(s,2H),3.95(s,4H),3.39(t,J=6.6Hz,4H),1.62–1.48(m,4H),1.25(s,36H),0.87(t,J=6.7Hz,6H).
Embodiment 2
Synthesizing of compound 6
In two mouthfuls of flasks of 250mL, add 5 (8.0g, 0.02mmol), under Ar gas protection, substitute gas three times, add anhydrous THF (35mL), the 1mol/L BH that dropwise adds THF to dissolve at 0 ℃ 3(28mL), rapid stirring 2 hours, drips 3mol/LNaOH (28mL).Rapid stirring 15 minutes, drips 30%H 2o 2(28mL), under room temperature, rapid stirring adds K for 30 minutes 2cO 3to saturated, CH 2cl 2extraction (50mL × 3), merges organic phase, distillation washing (50mL × 3), and anhydrous magnesium sulfate drying organic phase, removes by filter magnesium sulfate, revolves to steam to desolventize, and residuum is purified with silica gel column chromatography, obtains colourless liquid 6.5g, productive rate 79%. 1H?NMR(400MHz,CDCl 3):δ3.78(d,J=5.1,2.4Hz,1H),δ3.76(d,J=5.0Hz,1H),δ3.68(d,J=6.1Hz,1H),3.62–3.58(m,2H),3.52(m,J=9.4,6.0Hz,2H),3.47–3.25(m,4H),2.17(s,1H),1.55(d,J=10.2,3.9Hz,4H),1.46–1.03(m,36H),0.99–0.74(m,6H)。
Embodiment 3
Synthesizing of compound 7
In two mouthfuls of flasks of 500mL, add 6 (3.9g, 9.57mmol, 1eq.), TsCl (9.13g, 47.9mmol, 5eq.), under the protection of Ar gas, substitutes gas three times, adds anhydrous CH 2cl 2(80mL), pyridine (11.4g, 144mmol, 15eq.), at 25 ℃, rapid stirring 5 hours, uses CH 2cl 2extraction (50mL × 30), merge organic phase, organic phase is first washed (50mL × 1) with 1mol/L HCl, with distillation washing (50mL × 3), anhydrous magnesium sulfate drying organic phase, removes by filter magnesium sulfate again, revolve to steam and desolventize, residuum is purified with silica gel column chromatography, obtains weak yellow liquid 4.6g, productive rate 85%.
1H?NMR(400MHz,CDCl 3):δ7.81(d,J=8.3Hz,2H),7.36(d,J=8.0Hz,2H),4.12(d,J=5.6Hz,2H),3.46–3.23(m,8H),2.47(s,3H),2.20(q,J=11.5,5.8Hz,1H),1.54–1.40(m,4H),1.37–1.17(m,36H),0.90(t,J=6.8Hz,6H)。
Embodiment 4
Synthesizing of 3,5-dibromobenzene methyl ether (9)
In the round-bottomed flask of 500mL, add 3,5-bis-bromofluoro benzenes (8) (20.0g, 0.08mol, 1eq.) and after dry DMF (350mL), in round-bottomed flask, slowly add sodium methylate (5.2g, 0.09mol, 1.2eq.), under room temperature, vigorous stirring is spent the night, and then adds 5%HCl neutralization, stopped reaction.CH 2cl 2extraction (50mL × 3), distillation washing (50mL × 3) for organic phase, anhydrous magnesium sulfate drying organic phase, remove by filter magnesium sulfate, revolve to steam and obtain faint yellow solid except desolventizing, silica gel column chromatography is purified by (eluent: sherwood oil), obtains white solid 30g, productive rate 95%. 1H?NMR(400MHz,CDCl 3):δ7.25(t,J=1.6Hz,1H),6.99(d,J=1.6Hz,2H),3.78(s,3H).
Embodiment 5
Synthesizing of 3,5-dibromophenol (10)
In two mouthfuls of flasks of 250mL, add 3,5-dibromobenzene methyl ether (9) (5g, 18.8mmol, 1eq.), under the protection of Ar gas, add anhydrous CH 2cl 2(80mL), dropwise add BBr at 0 ℃ 3(3.5mL, 37.6mmol, 2eq.), keeps 0 ℃ of reaction to rise to room temperature after 3 hours, stopped reaction after lucifuge reaction trash ice cancellation in 2 days.Reaction solution CH 2cl 2extraction (50mL × 3), merge organic phase, distillation washing (50mL × 3), anhydrous magnesium sulfate drying, remove by filter magnesium sulfate, revolve steaming and desolventize, silica gel column chromatography purification (eluent: ether/sherwood oil=1/9) for residuum, obtain white solid 4.2g, productive rate 90%.Mp=86-89℃. 1H?NMR(400MHz,CDCl 3):δ7.28(t,J=2.0Hz,1H),6.97(t,2H),4.95(s,1H).
Embodiment 6
Synthesizing of compound 11
In two mouthfuls of flasks of 100mL, add 7 (4g, 6.7mmol, 1eq.), 3,5-dibromophenol (3g, 13.4mmol, 2eq.), K 2cO 3(9g, 67mmol, 10eq.), under the protection of Ar gas, adds anhydrous THF (50mL), backflow 48h, stopped reaction.Revolve to steam and remove THF, use CH 2cl 2extraction (50mL × 3), merge organic phase, distillation washing (50mL × 3), anhydrous magnesium sulfate drying, remove by filter magnesium sulfate, rotation is steamed and is desolventized, silica gel column chromatography purification (eluent: PE/EA=25/1) for residuum, obtain light yellow liquid 3.8g, productive rate 85%. 1H?NMR(400MHz,CDCl 3):δ7.25(t,J=1.5Hz,1H),7.04(d,J=1.5Hz,2H),4.02(t,J=10.2Hz,2H),3.57–3.47(m,4H),3.42(t,J=6.6Hz,4H),2.41–2.28(m,1H),1.56(d,J=13.5,6.7Hz,4H),1.40–1.21(m,36H),0.88(t,J=22.0,7.4Hz,6H).
Embodiment 7
Compound 2a's is synthetic
In 50mL two-mouth bottle bottle, add successively 11 (500mg, 0.74mmol), two tetramethyl ethylene ketones close two boron (413.8mg, 1.63mmol), PdCl 2(dppf) (35.56mg, 0.045mmol, 6%), KOAc (435.1mg; 4.44mmol, 6eq.), under the protection of Ar gas, substitute gas three times, add dry DMF (freezing deoxygenation) (20mL); be heated to 80 ℃, react stopped reaction 3 hours.Be chilled to after room temperature CH 2cl 2extraction (50mL × 3), merge organic phase, distillation washing (50mL × 3), anhydrous magnesium sulfate drying organic phase, removes by filter magnesium sulfate, revolves to steam to desolventize, silica gel column chromatography purification (eluent: PE/EA=8/1) for residuum, GPC separates, and obtains light yellow oil: 319.41mg, productive rate 56%. 1H?NMR(400MHz,CDCl 3)δ7.87(s,1H),7.46(s,2H),4.08(d,J=5.5Hz,2H),3.56(d,J=6.0Hz,4H),3.42(t,J=6.6Hz,4H),2.37(m,J=11.5,5.7Hz,1H),1.56(q,J=13.1,6.4Hz,4H),1.36(s,24H),1.27(s,36H),0.90(t,J=6.7Hz,6H).
Embodiment 8
Compound 3a's is synthetic
In the 25mL two-mouth bottle that magnetic agitation and reflux are housed, add successively 2a (100mg, 0.13mmol, 1eq.), the bromo-2-iodine pyrimidine of 5-(112.8mg, 0.40mmol, 3eq.), Pd (PPh 3) 4(8mg, 0.0066mmol, 5%mol), under the protection of Ar gas, adds the freezing deoxygenation of THF() the freezing deoxygenation of/Toluene() (10/5mL=2/1), 2mol/L K 2cO 3(freezing deoxygenation) (0.66mL, 10eq.), is heated to 85 ℃ of backflows, reacts stopped reaction after 24 hours.Be chilled to after room temperature, revolve and steam except desolventizing, CH 2cl 2extraction (50mL × 3), merge organic phase, distillation washing (50mL × 3), anhydrous magnesium sulfate drying organic phase, remove by filter magnesium sulfate, revolve steaming and desolventize, silica gel column chromatography purification (eluent: PE/EA=30/1) for residuum, obtain white solid 60mg, productive rate 56%. 1H?NMR(400MHz,CDCl 3)δ9.08(s,1H),8.88(s,4H),8.15(d,J=1.4Hz,2H),4.25(d,J=5.6Hz,2H),3.62(d,J=6.0Hz,4H),3.45(t,J=6.6Hz,4H),2.54–2.38(m,1H),1.59(m,J=14.6,7.5Hz,4H),1.24(s,36H),0.89(s,6H).
Embodiment 9
Compound I a synthesizes and separates
Add successively compound 2a (84mg, 0.1084mmol1eq.), compound 3a (90mg, 0.1084mmol, 1eq.), Pd (PPh to being equipped with in the 25mL two-mouth bottle of magnetic stir bar and reflux 3) 4(40mg, 0.0325mmol, 30%mmol), substitutes gas three times under argon shield, add the tetrahydrofuran (THF) 5mL of freezing deoxygenation, the toluene 2.5mL of freezing deoxygenation, the K of freezing deoxygenation 2cO 3the aqueous solution (2mol/L) 1mL, is heated to 80 ℃, back flow reaction 80h, stopped reaction.Be chilled to after room temperature, use CH 2cl 2extraction (50mL × 3), merge organic phase, distillation washing (50mL × 3), anhydrous magnesium sulfate drying, remove by filter magnesium sulfate, revolve steaming and desolventize, silica gel column chromatography purification (PE:EA=3:1) for residuum, residuum is further purified through preparing gel permeation chromatography (GPC), obtains following target compound:
I 1(n=1): productive rate is 11.5%.MALDI-TOF?Mass:Calcd.For?C 228H 372N 12O 18[M] +:m/z=3569.55;Found:3569.6. 1H?NMR(400MHz,THF)δ9.49(s,1H),9.30(s,4H),8.25(s,2H),7.86(s,1H),7.47(s,2H),4.33(d,J=5.8Hz,2H),4.29(d,J=5.8Hz,2H),3.66(t,J=5.5Hz,9H),3.48(t,J=6.5Hz,8H),2.46(d,J=3.1Hz,2H),1.60(dd,J=13.7,6.7Hz,10H),1.37–1.21(m,79H),0.86(t,J=6.7Hz,14H)。
I 2(n=2): productive rate is 9.3%.MALDI-TOF?Mass:Calcd.For?C 304H 496N 16O 24[M+Na] +:m/z=4778.78;Found:4779.5273。
I 3(n=3): productive rate is 7.7%.MALDI-TOF?Mass:Calcd.For?C 304H 496N 16O 24[M+Na] +:m/z=5967.76;Found:5968.8779。

Claims (10)

1. containing a pyrimidine group rigidity Conjugate macrocycle compound, it is characterized in that: the general structure of described compound is:
Figure FDA0000475024810000011
wherein n=1,2,3,4,5; Wherein R is independently selected from one or more in hydrophobicity long chain alkyl group, hydrophilic long-chain group, chirality long chain alkyl group, ester group, cyano group, amino, aryl, sulfydryl separately.
2. one according to claim 1, containing pyrimidine group rigidity Conjugate macrocycle compound, is characterized in that: described R is independently hydrophobicity long chain alkyl group or hydrophilic long-chain group separately, and compound is:
Figure FDA0000475024810000012
Figure FDA0000475024810000013
in one; Wherein n=1,2,3,4,5.
3. one according to claim 1, containing pyrimidine group rigidity Conjugate macrocycle compound, is characterized in that: described compound is expanded through side chain and is:
Figure FDA0000475024810000021
wherein n=1,2,3,4,5.
4. one according to claim 1, containing pyrimidine group rigidity Conjugate macrocycle compound, is characterized in that: the N atom on described compound pyrimidine group and Pt coordination, and the structural formula after coordination is:
Figure FDA0000475024810000022
in one, wherein n=1,2,3,4,5.
5. one according to claim 1, containing pyrimidine group rigidity Conjugate macrocycle compound, is characterized in that: the metal-complexing such as N atom and Pt, Pd or Ru on described compound pyrimidine group.
6. the preparation method containing pyrimidine group rigidity Conjugate macrocycle compound as claimed in claim 1, comprising:
(1) rigid element is with 3, 5-bis-bromofluoro benzenes are raw material, synthesize 3 by substitution reaction, 5-dibromobenzene methyl ether, again through boron tribromide demethylation reaction synthetic 3, 5-dibromophenol, it is starting raw material that linear portion adopts the chloro-2-chloromethyl propylene of 3-, through condensation, hydroboration oxidation, tosylation obtains linear portion intermediate, afterwards 3, 5-dibromophenol synthesizes 3 with linear portion intermediate by nucleophilic substitution reaction again under alkaline condition, 5-dibromobenzene long chain ether, utilize 3, 5-dibromobenzene long chain ether and two tetramethyl ethylene ketones close two boron to carry out Miyaura and reacts synthon II,
(2) bromo-2 iodine pyrimidines of monomer II and 5-are by Suzuki linked reaction synthon III;
(3) utilize monomer II and monomer II I synthetic containing pyrimidine group rigidity Conjugate macrocycle compound by Suzuki coupling one step to form the loop method.
7. the application containing pyrimidine group rigidity Conjugate macrocycle compound as claimed in claim 1, is characterized in that: the described pyrimidine group rigidity Conjugate macrocycle compound that contains is developed in functional materials as self-assembly unit molecular application.
8. the application containing pyrimidine group rigidity Conjugate macrocycle compound as claimed in claim 1, is characterized in that: the described coordination containing pyrimidine group rigidity Conjugate macrocycle compound and metal is for the preparation of the matrix material with difference in functionality.
9. the application containing pyrimidine group rigidity Conjugate macrocycle compound as claimed in claim 1, is characterized in that: described have reversibility containing pyrimidine group rigidity Conjugate macrocycle compound to sour responsiveness, for regulating and controlling fluorescent material research.
10. the application containing pyrimidine group rigidity Conjugate macrocycle compound as claimed in claim 1, is characterized in that: the matrix material by the size selectivity induction preparation to guest molecule with different optical and electricity.
CN201410086053.XA 2014-03-10 2014-03-10 A kind of containing pyrimidine group rigidity Conjugate macrocycle compound and its preparation method and application Expired - Fee Related CN103819479B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410086053.XA CN103819479B (en) 2014-03-10 2014-03-10 A kind of containing pyrimidine group rigidity Conjugate macrocycle compound and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410086053.XA CN103819479B (en) 2014-03-10 2014-03-10 A kind of containing pyrimidine group rigidity Conjugate macrocycle compound and its preparation method and application

Publications (2)

Publication Number Publication Date
CN103819479A true CN103819479A (en) 2014-05-28
CN103819479B CN103819479B (en) 2017-01-04

Family

ID=50754807

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410086053.XA Expired - Fee Related CN103819479B (en) 2014-03-10 2014-03-10 A kind of containing pyrimidine group rigidity Conjugate macrocycle compound and its preparation method and application

Country Status (1)

Country Link
CN (1) CN103819479B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109336894A (en) * 2018-11-07 2019-02-15 东华大学 One kind having AIE effect rigidity Conjugate macrocycle compound and its preparation and application

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042228A1 (en) * 1999-12-10 2001-06-14 Prometic Biosciences Ltd. Macrocyclic compounds and their use
WO2012110190A1 (en) * 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
CN103193784A (en) * 2013-04-07 2013-07-10 东华大学 Pyrimidine group-containing rigid conjugated macrocyclic compound, as well as preparation method and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001042228A1 (en) * 1999-12-10 2001-06-14 Prometic Biosciences Ltd. Macrocyclic compounds and their use
WO2012110190A1 (en) * 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
CN103193784A (en) * 2013-04-07 2013-07-10 东华大学 Pyrimidine group-containing rigid conjugated macrocyclic compound, as well as preparation method and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
VOLKER HENSEL等: "Repetitive construction of macrocyclic oligophenylenes", 《ANGEWANDTE CHEMIE》 *
XAVIER DROOGHAAG等: "Combined Experimental and Theoretical Study on the Raman and Raman Optical Activity Signatures of Pentamethylundecane Diastereoisomers", 《J. PHYS. CHEM. B》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109336894A (en) * 2018-11-07 2019-02-15 东华大学 One kind having AIE effect rigidity Conjugate macrocycle compound and its preparation and application
CN109336894B (en) * 2018-11-07 2021-08-10 东华大学 Rigid conjugated macrocyclic compound with AIE effect and preparation and application thereof

Also Published As

Publication number Publication date
CN103819479B (en) 2017-01-04

Similar Documents

Publication Publication Date Title
CN101943862B (en) Sulfonium salt photo-acid generator using stilbene as main body and preparation method thereof
CN104530105B (en) Two boron fluoride complexings two pyrroles's methine derivative organic dyestuff of a kind of diazosulfide or benzene 1,4-Dithiapentalene bridging and preparation method thereof
CN104892566A (en) Preparation method of 2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
KR101994902B1 (en) Organoboron compound and method for manufacturing the same
CN106883207A (en) A kind of preparation method of trimeric indenyl bicoumarin fluorescent dye
CN110483483A (en) A kind of multiple tooth nitrogen ligand compound of chirality and its preparation method and application
CN104114563A (en) Intermediate for acenedichalcogenophene derivative and method for synthesizing same
CN103819479A (en) Pyrimidine group contained rigid conjugated macrocyclic compound as well as preparation method and application thereof
CN109574906A (en) A kind of preparation method of 3,3 '-two Indoleacetic esters
CN104803978B (en) A kind of preparation method of esomeprazole magnesium
CN109293700A (en) Chiral diphosphine ligand, preparation method, intermediate and application
JP6132656B2 (en) Method for producing picene and derivatives thereof
CN103772433A (en) Synthetic method of chemiluminescence reagent AMPPD for immunization analysis
CN103193784B (en) A kind of containing pyrimidine group rigidity Conjugate macrocycle compound and its preparation method and application
CN108675918B (en) Synthesis method of piceatannol
CN101220016A (en) Method for synthesizing 4-hydroxyl coumarin and derivant thereof
CN109456301B (en) Crown ether-containing HBC compound and preparation and application thereof
CN104558005B (en) The method of second-order nonlinear optical chromophore of the microwave synthesis with D π A structures
CN110386903B (en) Tetrazine-containing oligomeric phenylene acetylene compound and preparation method thereof
CN106478627A (en) A kind of 6,12,18 triaryl, 5,11,17 benzo three quinoline and its synthetic method
CN105969336A (en) Dendritic polymer structure based triplet-triplet annihilation upconversion luminescent material
CN101555219A (en) Method for preparing carlix (4) arene derivative containing sulfur and hydroxyl groups
CN104710284A (en) Method for preparing 2,2'-dihydroxy diphenyl
CN103242344A (en) Sulfur-hybridized molecular graphene compound and preparation and applications thereof
TWI833610B (en) Method and intermediates for preparing tricyclic compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170104

Termination date: 20190310